News

Pharmaceutical imports to the U.S. jumped in March, as drugmakers try to avoid any potential tariffs on the sector. Read more ...
A drug manufacturer plans to add 200 jobs to its workforce of 800 people in Yaphank to make medical devices for another ...
Wesley Pharmaceuticals' latest facility opening aligns with broader state initiatives, potentially reshaping Orlando's job ...
Discover key insights from Collegium Pharmaceutical's Q1 2025 earnings call: 23% revenue growth, Jornay PM's market success, sales force expansion & ...
New Jersey-based pharmaceutical giant Merck is investing $1 billion in what company executives described as a continued commitment to growing investments in United States manufacturing and jobs. Merck ...
In an industry dominated by first-time entrepreneurs and tech-focused founders, EarlyJobs stands out with leadership that ...
This episode takes us to Boston where Japanese companies fiercely compete to recruit bilingual talent at the world’s biggest ...
The pharma giant's chief exec Emma Walmsley (pictured) said European nations faced 'tough choices' on investment'.
AstraZeneca derived about 40 per cent of its sales from the US in the first three months of the year and had already committed to investing $3.5bn in America by the end of 2026 as part of a plan to ...
"Pharmaceutical industry jobs are especially important here in Oxfordshire, with Milton Park in my constituency being a crucial hub for pharmaceutical innovation. "It is vital that they are protected.
The report, not made public, was commissioned by the main US pharmaceutical lobby, the Pharmaceutical Research and Manufacturers of America.
The pharmaceutical company said the profit was driven by a higher gross margin and slower operating expense growth.